NDC11 55651062001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55651-0620-01 | 55651-0620 |
| 55651-0620-1 | 55651-0620 |
| 55651-620-01 | 55651-620 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Redness and Dry Eye Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | KC Pharmaceuticals, Inc | 4682f68d-6bdd-d860-e063-6394a90a2b52 | 2025-12-21 | Warnings | 55651-620-01 55651-620 55651062001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.